Source: Journal of the American College of Cardiology. Conference titles: Annual Scientific Session and Expo (ACC). Unidade: FM
Subjects: PLAQUETAS, PESO MOLECULAR, DOENÇAS CARDIOVASCULARES
ABNT
ARANTES, Flavia Bittar Britto et al. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease. Journal of the American College of Cardiology. New York: Elsevier. Disponível em: https://doi.org/10.1016/S0735-1097(17)33597-0. Acesso em: 13 out. 2024. , 2017APA
Arantes, F. B. B., Menezes, F., Franci, A., Barbosa, C., Dalçoquio, T. F., Nakashima, C. K., et al. (2017). Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease. Journal of the American College of Cardiology. New York: Elsevier. doi:10.1016/S0735-1097(17)33597-0NLM
Arantes FBB, Menezes F, Franci A, Barbosa C, Dalçoquio TF, Nakashima CK, Ferrari A, Scanavini Filho M, Furtado R, Baracioli L, Ramires J, Kalil-Filho R, Nicolau J. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease [Internet]. Journal of the American College of Cardiology. 2017 ; 69 208.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/S0735-1097(17)33597-0Vancouver
Arantes FBB, Menezes F, Franci A, Barbosa C, Dalçoquio TF, Nakashima CK, Ferrari A, Scanavini Filho M, Furtado R, Baracioli L, Ramires J, Kalil-Filho R, Nicolau J. Effects of low molecular weight heparin versus dabigatran on platelet aggregation in patients with stable coronary artery disease [Internet]. Journal of the American College of Cardiology. 2017 ; 69 208.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/S0735-1097(17)33597-0